JenniferIbrahimMD

PubMed

• 36 citations
  A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration
  M. Judith Peterschmitt, Gerald F. Cox, Jennifer Ibrahim, James MacDougall, Lisa H. Underhill, Palni Patel, Sebastiaan J.M. Gaemers> ;Blood Cells, Molecules & Diseases. 2018 Feb 1
• Letter to the Editor on "Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options".
  Jennifer Ibrahim, Rebecca Call> ;Hospital Pharmacy. 2017 Oct 10
• 11 citations
  Clinical response to eliglustat in treatment-naïve patients with Gaucher disease type 1: Post-hoc comparison to imiglucerase-treated patients enrolled in the Internati...
  Jennifer Ibrahim, Lisa H. Underhill, John S. Taylor, Jennifer Angell, M. Judith Peterschmitt> ;Molecular Genetics and Metabolism Reports. 2016 Jun 27
• 119 citations
  High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype-Phen...
  Kitiwan Rojnueangnit, Jing Xie, Alicia Gomes, Angela Sharp, Tom Callens, Yunjia Chen, Ying Liu, Meagan E. Cochran, Mary Alice Abbott, Joan F. Atkin, Dusica Babovic-Vuk...> ;Human Mutation. 2015 Nov 1
• 132 citations
  The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization system.
  Fady M. Mikhail, Rachel D. Burnside, Brooke Rush, Jennifer Ibrahim, Robin Godshalk, S. Lane Rutledge, Nathaniel H. Robin, Maria Descartes, Andrew J. Carroll> ;Genetics in Medicine. 2014 Jan 1
• 5 citations
  Interstitial Deletion of Proximal 8q Including Part of the Centromere from Unbalanced Segregation of a Paternal Deletion/Marker Karyotype with Neocentromere Formation ...
  Rachel D. Burnside, J. Ibrahim, C. Flora, Stuart Schwartz, James Tepperberg, Peter Papenhausen, Peter E. Warburton> ;Cytogenetic and Genome Research. 2011 Jan 6
• Join now to see all